MORRISON C. ENGLAND, Jr., District Judge.
Through the present action, Plaintiffs Thomas Aoki, M.D. ("Aoki"), and Aoki Diabetes Research Institute ("ADRI") (collectively, "Plaintiffs") allege a variety of causes of action arising around the development, patenting, and licensing of therapies intended for the treatment of diabetes. Pending before the Court is Plaintiffs' Motion to Disqualify Defendant Gregory Gilbert ("Gilbert") and affiliated counsel James L. Brunello ("Brunello") as counsel for several of Gilbert's co-Defendants. For the following reasons, Plaintiffs' Motion is DENIED without prejudice.
Aoki, a physician licensed to practice in California, founded ADRI in 1986 to further his research efforts into the areas of diabetes and metabolism. ADRI also provides some clinical care using an intravenous insulin therapy called metabolic activation therapy or MAT® treatment. Aoki is the sole inventor and developer of, and has received a patent for, that treatment.
During development of the therapy and thereafter Aoki and ADRI also developed trade secret know-how related to the use and application of that technology. In addition, Aoki developed additional treatment-related methods and systems for which he obtained further patents (collectively, all above patents are referred to as "the Patents"). Aoki purportedly licensed use of the Patents to ADRI.
According to Aoki, at some point he retained Gilbert, a California attorney, to act as his personal counsel. At the same time, Gilbert became engaged in business transactions with Aoki and set up legal entities, including ADRI, to exploit Aoki's technology. Gilbert acted as counsel for those legal entities as well. In fact, Gilbert purportedly drafted nearly every legal document for both the entities and for Aoki and provided legal advice to Plaintiffs over the course of many years, until their relationship dissolved in late 2002 or early 2003.
After Plaintiffs' relationship with Gilbert ended, Gilbert allegedly proceeded to falsely assert that he, or entities with which he is affiliated, holds all right, title and interest in the MAT® treatment. More specifically, Gilbert purportedly acted in concert with the remaining Defendants to set up clinics where the MAT® treatment is now offered. Gilbert also allegedly made false and misleading statements to patients or would-be patients regarding the status and efficacy of the MAT® treatment as well as regarding available payment options.
Plaintiffs thus filed this action bringing claims against all Defendants for patent infringement, copyright infringement, trade secret misappropriation, false and misleading advertising, and unfair competition. In addition, Plaintiffs allege breach of fiduciary duty and breach of confidential relationship claims against Defendant Gilbert alone.
When Gilbert responded to the Complaint
In support of their Motion, Plaintiffs submitted a 2003 email, purportedly drafted by Gilbert, indicating he believed Aoki had "personally been [his] client for many, many years."
Finally, Plaintiffs submitted a partial transcript of Gilbert's testimony from a June 2004 evidentiary hearing before a Nevada state court.
In addition, Gilbert stated in his testimony that he handled ADRI's "equipment and law and contracts, and all commercial activity, running the company, hiring the people."
According to Gilbert, he has been involved in the development of diabetes technologies for more than twenty-five years, ever since his daughter was diagnosed with Type 1 diabetes at age 2. At that time, Gilbert was a practicing lawyer and the Chief Executive Officer ("CEO") of an international innovative pump manufacturing company. After his daughter's diagnosis, Gilbert began work on designing an insulin pump for use in the treatment of diabetes. Due to his increasing diabetes-related work, Gilbert eventually met Aoki, and the two thereafter partnered together to develop and commercialize a new approach to the treatment of diabetes using Aoki's technology and Gilbert's pumps.
Gilbert formed ADRI in approximately 1986 or 1987 and thereafter served as its Executive Director. After realizing that fund-raising presented an issue for a non-profit entity, Gilbert formed a "for profit" company, AMSys, to raise additional funds. According to Gilbert, at AMSys' formation, Aoki licensed his technology to that new entity. In the meantime, Gilbert continued working on pumps through his own affiliated entities, namely some of the Bionica Defendants. Subsequently, over the course of many years, Gilbert became the CEO of AMSys and he and Aoki reverse merged AMSys into a new company. Eventually, after that new company experienced difficulties, Gilbert purchased the license himself via one of his other entities. All disputes between the parties were purportedly eventually resolved by execution of a Settlement Agreement and Release, which Gilbert argues operated to assign him the license rights in the pertinent technology.
According to Gilbert, he did not represent Aoki with respect to the matters at issue in this lawsuit, which are the various licenses issued or transferred to him. To the contrary, Gilbert claims that in relation to each of these proceedings he represented himself and his own companies. Gilbert thus argues Plaintiffs have shown no basis for disqualification.
In deciding motions for disqualification, the court applies the relevant state law.
Cal. Rules Professional Conduct, Rule 3-310 (E).
Pursuant to that rule, "[w]here an attorney successively represents clients with adverse interests, and where the subjects of the two representations are substantially related, the need to protect the first client's confidential information requires that the attorney be disqualified from the second representation."
In applying the "substantial relationship" test, "courts focus less on the meaning of the words substantial and relationship and look instead at the practical consequences of the attorney's representation of the former client."
Throughout its analysis, the Court should nonetheless remain cognizant that "[a] motion to disqualify counsel is a drastic measure which courts should hesitate to impose except when of absolute necessity."
Plaintiffs seek to disqualify Gilbert and related counsel Brunello due to "Gilbert's nearly 20-year history as the personal attorney for Dr. Aoki and general counsel for ADRI." Motion, 1:9-11. Plaintiffs' Motion fails for several reasons.
First, the only evidence Plaintiffs have produced to demonstrate the existence of a 20-year attorney client relationship is an almost decade-old e-mail, a declaration submitted by Aoki in a Nevada state court proceeding and excerpts of testimony Gilbert gave in another state court proceeding. Most of the statements included within these documents consist of legal conclusions, and they all suffer from a variety of additional flaws as well, not the least of which is that they are aged, lack foundation, are taken out of context and are comprised primarily of hearsay. In sum, Plaintiffs' evidence is weak, at best.
Moreover, evidentiary shortcomings aside, while it is clear that Gilbert did represent ADRI and Aoki each in some capacity at some time, there is nothing before the Court to indicate Gilbert represented Plaintiffs with respect to matters having a substantial relationship to the current dispute. In fact, the only statements that potentially give the Court any pause in this regard are those pertaining to Gilbert's work on the Patents. That being said, it remains unclear exactly what Gilbert's role was in prosecuting those Patents. Indeed, while Gilbert does not appear to deny he did patent work for Aoki, it appears to the Court that Gilbert may have been doing so on his own behalf, or on behalf of the other companies of which he was a principal, in furtherance of a joint venture, in which case Plaintiffs' confidential communications with counsel would not necessarily be protected.
Finally, even if the Court had been provided concrete evidence that Gilbert represented Plaintiffs alone regarding the prosecution of those Patents, it does not appear to this Court that any such prosecution will be at issue in this litigation. There is no indication in the record that Defendants intend to challenge the validity of the Patents or Aoki's development of the underlying technology. Instead, the issues that will be litigated here arose much later and involve the validity of subsequent agreements and licenses purportedly transferring the rights to the Patents to third parties and then to Gilbert. No facts before the Court indicate that Gilbert represented either Plaintiff (especially outside of some sort of joint representation) with respect to these subsequent transactions.
Ultimately, the weak record before the Court, coupled with the lengthy and contentious history among the parties, leaves the Court with no immediate way to parse out the facts. The Court is simply not willing to take such a drastic step as to disqualify counsel without a much more solid showing that counsel previously acted as Plaintiffs' attorney and that the course of that former representation is substantially related to the current litigation. Stated another way, Plaintiffs are obligated to
For the reasons just stated, Plaintiffs' Motion to Disqualify Attorneys (ECF No. 41) is DENIED without prejudice. In addition, for clarity of the Court's docket, the various pending Motions to Dismiss and the Motion for More Definite Statement originally filed in December of 2011 (ECF Nos. 7-10) are DENIED without prejudice as well. Not later than five (5) days following the date this Memorandum and Order is electronically filed, Defendants shall either re-notice those dispositive motions on the Court's regular civil calendar or otherwise respond to Plaintiffs' Complaint.
IT IS SO ORDERED.